Saccharin could sweeten the deal for cancer-fighting drugs

Saccharin could sweeten the deal for cancer-fighting drugs

In an exciting new discovery that could bring about significant progress in cancer research, it appears that saccharin, an artificial sweetener, can bind selectively to a protein involved in many aggressive forms of cancer. Since the protein is similar to many others that are abundant in the body, finding a way to target this specific molecule is a critical first step in synthesizing drugs that inhibit its function. This research has been presented to the American Chemical Society and further developments await.